CXCR2 and breast cancer: Prostaglandin-endoperoxide synthase 2 (PTGS2) might mediate the CXCR2 signaling to inversely control the breast cancer metastasis and chemoresistance through the regulation of EMT, apoptosis, and senescence (Xu et al., 2018).